SCHEMBL16145772

SCHEMBL16145772

[CH]1NCC[C@@H]2CCCC[C@@H]12

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5159 1.00 ALDH1A1 (0.33) ALDH1A1
SCHEMBL7283678 1.00 ALDH1A1 (0.33) ALDH1A1
SCHEMBL1477516 1.00 ALDH1A1 (0.33) ALDH1A1
SCHEMBL1476914 1.00 ALDH1A1 (0.33) ALDH1A1
SCHEMBL14720581 0.95
SCHEMBL10873496 0.85
SCHEMBL7815 0.77
SCHEMBL14740988 0.77
SCHEMBL9938216 0.73 PNMT (0.34)
SCHEMBL37649 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107072946-B Lipids and lipid compositions for delivery of active agents 诺华股份有限公司 2022-01-11 CN disclosed
CN-107879960-B Lipids and lipid compositions for delivery of active ingredients 诺华股份有限公司 2021-06-22 CN disclosed
CN-106794141-B Method for encapsulating nucleic acids in lipid nanoparticle hosts 诺华股份有限公司 2021-05-28 CN disclosed
US-11013696-B2 Lipids and lipid compositions for the delivery of active agents NOVARTIS AG (CH) 2021-05-25 US disclosed
US-10792361-B2 Lipids and lipid compositions for the delivery of active agents NOVARTIS AG (CH) 2020-10-06 US disclosed
US-20190321295-A1 Method of Encapsulating a Nucleic Acid in a Lipid Nanoparticle Host NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. 2019-10-24 US disclosed
US-20180369386-A1 LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC. 2018-12-27 US disclosed
US-9504747-B2 Lipids and lipid compositions for the delivery of active agents NOVARTIS AG (CH) 2016-11-29 US disclosed
US-20140303232-A1 LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS NOVARTIS AG (CH) 2014-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190321295-A1 Method of Encapsulating a Nucleic Acid in a Lipid Nanoparticle Host POLN, POLRMT, RNGTT ALDH1A1 2314/4885
US-20180369386-A1 LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS LIPA, LPAR1, LPAR4 ALDH1A1 2488/4885
US-11013696-B2 Lipids and lipid compositions for the delivery of active agents PHOSPHO1, SGMS1, LIPA ALDH1A1 1564/4885
US-10792361-B2 Lipids and lipid compositions for the delivery of active agents LIPA, LPAR1, LPAR4 ALDH1A1 2488/4885
US-20140303232-A1 LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS LIPA, LPAR1, LPAR4 ALDH1A1 2488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.